MRI holds high promise to diagnose Parkinson’s disease (PD) at clinical field strength B0. However, it remains unclear which B0 optimizes T2* contrast in substantia nigra, which provides high diagnostic accuracy. We used quantitative MRI at B0=1.5T-9.4T, MR microscopy, and histochemistry to characterize the field dependence of the major contributors to R2* (1/T2*): dopaminergic neurons, ferritin, and myelin. R2* maps were similar at B0=3T-9.4T, and all contributions scaled approximately linearly with B0. Hence, the contrast mechanisms are similar across currently available MRI field strengths in vivo, which informs the design of novel PD biomarkers.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords